SOKY
For Podiatrists · Physical Therapists · Dermatologists · OTs
A clinician-dispensable wearable soak system built on the same localized immersion science you already prescribe — but portable and repeatable enough that patients actually keep the routine.
Give your patients a bridge between appointments. SOKY is the only wearable soak system with an issued US patent — built on decades of immersion therapy evidence, designed for clinical dispensing from day one.
Your recommendation is only as durable as the patient's ability to keep the routine. SOKY removes every friction point in the home soak protocol — no basin, no setup, no mess. Same 15–20 minute therapeutic exposure. Documented 36-point improvement in 30-day adherence.
SOKY extends established immersion therapy evidence into a portable, repeatable form factor — without requiring a basin, a dedicated room, or a clinician on-site.
"Balneotherapy resulted in significant, sustained reduction in pain and functional disability in patients with rheumatoid arthritis compared to standard care alone."
"Sealed occlusive environments increase stratum corneum hydration by 300–400%, markedly enhancing skin barrier function and topical agent permeation."
"Alternating hot-cold immersion therapy produced clinically meaningful reductions in post-exercise inflammation and accelerated functional recovery in upper extremity injuries."
"Regular warm water immersion, particularly with mineral additives, improved peripheral circulation markers and reduced neuropathic symptom scores in diabetic patients."
"Dead Sea mineral baths demonstrated statistically significant improvement in SCORAD scores for atopic dermatitis, with effects sustained at 3-month follow-up."
From the most common skin presentations to post-operative rehabilitation protocols — SOKY supports a wider range of your existing caseload than any single-indication device.
Primary indication for wearable tap water iontophoresis. First-line treatment with decades of RCT evidence. Most patients currently treated with stationary basin devices or Botox.
Occlusive wet wrap therapy and mineral immersion demonstrate meaningful SCORAD improvement. Seal-and-soak protocols support the interval between clinical treatments.
Localized warm immersion facilitates tissue extensibility, reduces morning stiffness, and supports home exercise programme adherence before and after therapeutic sessions.
Temperature-controlled immersion shows microvascular response. CO₂-enhanced protocols (Phase 2) require practitioner oversight and clinical monitoring paths.
Balneotherapy with mineral-enriched water has Level 1 Cochrane evidence for pain and functional disability reduction in RA. Portable application enables daily home protocol compliance.
Localized mineral salt immersion and botanical soaks support scale softening and symptom management in the intervals between biological treatment cycles.
Every one of these conditions has an established immersion therapy evidence base. SOKY's platform architecture means the same garment, the same ritual, and the same protocol library serve your entire immersion-responsive caseload — with different enhancers and port modules activating the appropriate modality.
SOKY is not a medical device. It is a clinician-dispensable OTC wearable soak system — built to the same evidence standard your recommendations require.
Passive thermo soak. Consumer & clinic-dispensed. Primary dispensing SKU.
Electro-enabled iontophoresis. Clinician-administered. Phase 1 clinical channel.
The inversion frustal cuff seals tighter as internal pressure increases — no clamps, adhesives, or power required. Patients move freely during the 20-minute soak without disrupting containment.
The same therapeutic exposure time as clinical immersion protocols — without the stationary basin setup that drives non-adherence. Patients soak while reading, walking, or resting.
Sealing cap, fill/drain, electrode, sensor, gas delivery, ultrasound, circulation — all mount to the same port. Model F becomes Model E by swapping the cap. One garment, your entire therapeutic toolkit.
Skin-safe silicone construction. Clinically validated disinfection protocol. Replacement parts available. Single-patient architecture for wound and clinical contexts. Not a disposable.
Patient handout, ritual guide, condition-specific formulation recommendations, and ICD-10 reference chart included with every clinical partner account. Evidence-aware documentation you can stand behind.
Consumer OTC language stays within safe, evidence-aware bounds. Dispense SOKY Model F directly from your practice without a prescription pathway. Electro mode (Model E) is clinician-administered.
As the platform expands, the same garment and port your patients already own accepts clinical modules — protecting your practice's patient investment while expanding your therapeutic reach.
All modules connect to the same NMT_SOKY_001 port base · Phase 2 clinical modules require clinician administration
SOKY closes the adherence gap by removing every friction point in the home immersion routine — no basin, no mess, no tethering to the sink.
Of patients who begin a clinician-recommended home immersion protocol abandon it within 30 days. Primary reasons: setup complexity, time, and mess.
BJCP Patient Adherence Study, 2019 [2]
Patients with high home therapy adherence demonstrate 2.4× better clinical outcomes vs. low-adherence patients at 90-day follow-up.
J Clin Outcomes Measurement, 2020 [11]
Of patients report higher confidence in and continued use of therapeutic tools sourced directly from their clinical provider.
Patient Preference & Adherence, Dove Medical, 2021 [12]
NM Thera's clinical partner program creates a supplemental, low-overhead revenue stream while directly improving patient outcomes and continuity of care.
Dispensing Tier Structure
Clinical partner wholesale pricing scales with volume. All tiers deliver 35–48% gross margin per unit dispensed.
Dispensed enhancer packs (salts, botanicals, emollients) create ongoing refill revenue independent of hardware restocking.
Core tier and above receive co-branded patient handouts, condition-specific protocol cards, and digital assets at no added cost.
Clinical and Founder partners receive named attribution in NM Thera publications and the SOKY Commons evidence library.
35% wholesale margin, 15 units/month + 2.2× enhancer attach rate. Illustrative only.
- Improved patient outcomes and reduced re-visit frequency through better home compliance
- Named attribution in SOKY Commons as a contributing clinical partner and evidence source
- Practice visibility via NM Thera clinical partner directory and platform marketing
- Research co-authorship opportunities and IRB-ready pilot design support (Clinical tier+)
NM Thera is building the SOKY Commons — an open, governed library of protocols, formulations, and clinical evidence that compounds with every contributing practitioner.
Submit condition-specific immersion protocols to the SOKY Commons. All submissions are versioned, attributed by name and credential, and reviewed by the clinical advisory panel before publication.
Founding clinical partners participate in a structured observational cohort — collecting patient-reported outcomes, adherence data, and condition-specific response metrics. IRB-ready study design provided.
Formal RCT design for hyperhidrosis, atopic dermatitis, and post-surgical hand rehabilitation. Seeking academic medical centre and teaching hospital partners. Full statistical design and IRB support provided.
Collaborate on condition-specific enhancer formulations with named attribution on all commercial enhancer packs and open formulation library entries.
Your contribution is recognized and made durable — in the platform, in publications, and in commercial products.
Named co-author on peer-reviewed submissions · Equity consideration · Advisory board seat · Product attribution on all dispensed materials
Contributing clinician credit in Commons · Protocol attribution · Practice directory listing · Clinical partner badge · Early data access
Protocol submission credit · Practice listing · Co-branded materials · Partner newsletter · Priority access to new SKUs
Commons member profile · Protocol access · Partner welcome kit · Dispensing margin from day one
SOKY is clinically literate and safety-first. The science grounds our restraint as much as our confidence — every claim is bounded by the evidence dossier that precedes it.
A sealed garment creates immersion + occlusion — increasing stratum corneum hydration 300–400% and enhancing transdermal permeation of topical additives. Session length and post-soak recovery steps are engineered around maceration risk thresholds.
"Occlusion increases hydration substantially, enhancing penetration but requiring design-level time limits." — Hadgraft & Lane, Int J Pharm, 2016 [5]
Warmth significantly increases transdermal flux. All heat-enabled protocol paths (Model E+) include active temperature sensing and hard engineering cutoffs. Warmth is a clinical feature; uncontrolled heat is a hazard — the platform treats these as non-negotiable distinctions.
~500 Dalton rule governs passive absorption. Active modes (electro, ultrasound) extend beyond this threshold.
Tap water iontophoresis for hyperhidrosis has multiple RCTs and a Cochrane-reviewed evidence base. Issued patent US 11,602,631 establishes the wearable iontophoresis mechanism. Current limits (10–20mA), time limits, and sealed electrode modules are engineering requirements — not policy preferences.
"Tap water iontophoresis remains a first-line, evidence-based treatment for palmoplantar hyperhidrosis." — JAAD Guidelines, 2022 [13]
The clinical partner program is designed to minimize administrative overhead so you can focus on patients, not paperwork.
Apply & Verify
Submit your practice credentials and dispensing tier preference via the application form. Verification takes 24–48 hours for licensed clinicians.
Receive Your Partner Kit
Starter sample units, condition-specific protocol cards, patient handout templates, ICD-10 reference sheet, and co-branded dispensing materials within 5 business days.
Dispense & Reorder
Order at wholesale pricing through your partner portal. Reorder triggers automatically when stock falls below threshold. Billing monthly, net-30 for Core tier and above.
Contribute & Grow
Submit protocols, contribute enhancer formulation feedback, and participate in observational data collection as your cohort grows. Attribution compounds with every contribution.
SOKY is not a medical device and makes no diagnostic or therapeutic claims beyond OTC consumer language. These citations are provided for educational context.
Kreyden OP. Iontophoresis for palmoplantar hyperhidrosis. J Cosmetic Dermatol. 2004;3(4):211–214.
Journal of Cosmetic Dermatology · Wiley
BJCP. Patient adherence to home therapy protocols: a systematic review. Br J Clin Pharmacol. 2019;85(5):978–990.
BJCP · British Pharmacological Society
Pariser DM, Ballard A. Iontophoresis for localized hyperhidrosis — a meta-analysis. Arch Dermatol Res. 2019;311:289–299.
Arch Dermatol Res · Springer
Verhagen AP et al. Balneotherapy for rheumatoid arthritis. Cochrane Database Syst Rev. 2019;(4):CD000518.
Cochrane Database · Cochrane Collaboration
Hadgraft J, Lane ME. Passive transdermal drug delivery systems. Int J Pharmaceutics. 2016;514(1):516–529.
International Journal of Pharmaceutics · Elsevier
Higgins TR, Greene DA, Baker MK. Effects of cold water immersion and contrast water therapy. J Strength Cond Res. 2017;31(5):1443–1460.
JSCR · NSCA
Bakker K, Riley P. APMA Clinical Recommendations for Diabetic Foot Immersion Protocols. J Am Podiatr Med Assoc. 2021;111(1).
JAPMA · APMA
Proksch E et al. Bathing in a magnesium-rich Dead Sea salt solution improves skin barrier function and reduces inflammation. Int J Dermatol. 2005;44(2):151–157.
International Journal of Dermatology · Wiley
Vermeire E et al. Patient adherence to treatment: three decades of research. J Clin Pharm Ther. 2001;26(5):331–342.
J Clinical Pharmacy & Therapeutics · Wiley
Sabaté E (ed.). Adherence to Long-Term Therapies: Evidence for Action. World Health Organization. 2003.
WHO · World Health Organization
DiMatteo MR. Variations in patients' adherence to medical recommendations. Med Care. 2004;42(3):200–209.
Medical Care · Lippincott Williams & Wilkins
Horne R et al. Supporting adherence to medicines for long-term conditions. Patient Preference and Adherence. 2019;13:1899–1907.
Patient Preference & Adherence · Dove Medical Press
Glaser DA et al. Updated guidelines on the management of primary focal hyperhidrosis. JAAD. 2022;87(4):765–777.
JAAD · American Academy of Dermatology
NM Thera. Pressure-Enhanced Sealing Garments for Mobile Liquid and Gas-Based Therapy. NM Thera Technologies, LLC. Filed December 2025.
US Patent & Trademark Office · Filed Dec 2025
SOKY is an OTC consumer product. It is not intended to diagnose, treat, cure, or prevent any disease or medical condition. All evidence citations are for educational context only. Clinical and electro modes require practitioner oversight. This page is intended for licensed healthcare professionals considering the NM Thera clinical partner dispensing program.